NEW YORK (GenomeWeb) – The National Institutes of Health will fund new projects that delve into the ethical, legal, and social implications (ELSI) of human genomics research, such as efforts to identify, analyze, and address the ways in which advances in genomics impact health sciences and medicine.

These studies may examine the ways in which genomics is affecting society and use approaches from different disciplines, such as ethics, economics, law, clinical and computational sciences, philosophy, epidemiology, and other areas.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.